SCHEMBL4824754

SCHEMBL4824754

O=C(O)[C@@H](O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL322139 1.00
SCHEMBL322140 1.00
SCHEMBL5911568 0.78
SCHEMBL20495509 0.76 HTT (0.32)
SCHEMBL19874878 0.75 CPT2 (0.36)
SCHEMBL16837789 0.75
SCHEMBL10451804 0.75
SCHEMBL31380646 0.75 CPT2 (0.41)
SCHEMBL8603986 0.73
SCHEMBL21273861 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353817-A1 INTERLUKIN-17A INHIBITORS AND USES THEREOF GILEAD SCIENCES INC (US) 2025-11-20 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-3339296-A1 HYDROXYTRIAZINE COMPOUND AND MEDICAL USE THEREOF Japan Tobacco, Inc. (JP) 2018-06-27 EP disclosed
EP-2680840-A1 NOVEL BENZODIOXOLE PIPERIDINE COMPOUNDS F.HOFFMANN-LA ROCHE AG (CH) 2014-01-08 EP disclosed
US-8598357-B2 Benzodioxole piperidine compounds HOFFMANN-LA ROCHE INC. (US) 2013-12-03 US disclosed
WO-2012117001-A1 NOVEL BENZODIOXOLE PIPERIDINE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2012-09-07 WO disclosed
US-20120225868-A1 NOVEL BENZODIOXOLE PIPERIDINE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2012-09-06 US disclosed
US-20080262083-A1 ANTIBACTERIAL AGENTS IDEXX LABORATORIES, INC. (US) 2008-10-23 US disclosed
US-7402697-B2 chloramphenicols; e.g. D-(threo)-1-p-methylsulfonyl-2-amino-3-fluoro-1-propanol(\"Fenicol Compounds\"); antibiotics; veterinary medicine; side effect reducion IDEXX LABORATORIES INC. (US) 2008-07-22 US disclosed
EP-1836162-A2 ANTIBACTERIAL AGENTS IDEXX Laboratories Inc (US) 2007-09-26 EP disclosed
WO-2007058639-A2 ANTIBACTERIAL AGENTS IDEXX LABORATORIES INC. (US) 2007-05-24 WO disclosed
US-20060047138-A1 Antibacterial agents IDEXX LABORATORIES INC. 2006-03-02 US disclosed